BSE Live
Oct 01, 16:01Prev. Close
340.85
Open Price
340.20
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Oct 01, 15:57Prev. Close
341.00
Open Price
341.00
Bid Price (Qty.)
346.45 (61)
Offer Price (Qty.)
0.00 (0)
Balance Sheet of Biocon (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
EQUITIES AND LIABILITIES | ||||||
SHAREHOLDER'S FUNDS | ||||||
Equity Share Capital | 600.00 | 300.00 | 300.00 | 100.00 | 100.00 | |
Total Share Capital | 600.00 | 300.00 | 300.00 | 100.00 | 100.00 | |
Reserves and Surplus | 6,936.40 | 6,814.50 | 6,437.70 | 6,440.20 | 5,895.70 | |
Total Reserves and Surplus | 6,937.30 | 6,815.40 | 6,438.60 | 6,441.10 | 5,896.60 | |
Total Shareholders Funds | 7,537.30 | 7,115.40 | 6,738.60 | 6,541.10 | 5,996.60 | |
NON-CURRENT LIABILITIES | ||||||
Long Term Borrowings | 0.70 | 1.40 | 67.20 | 132.40 | 136.50 | |
Deferred Tax Liabilities [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.90 | |
Other Long Term Liabilities | 23.40 | 105.50 | 72.30 | 76.90 | 92.00 | |
Long Term Provisions | 21.40 | 24.80 | 17.20 | 13.30 | 9.50 | |
Total Non-Current Liabilities | 45.50 | 131.70 | 156.70 | 222.60 | 238.90 | |
CURRENT LIABILITIES | ||||||
Short Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 225.50 | |
Trade Payables | 521.20 | 643.90 | 579.70 | 450.50 | 394.40 | |
Other Current Liabilities | 182.40 | 294.60 | 220.30 | 222.70 | 214.20 | |
Short Term Provisions | 24.40 | 54.80 | 31.60 | 32.00 | 28.50 | |
Total Current Liabilities | 728.00 | 993.30 | 831.60 | 705.20 | 862.60 | |
Total Capital And Liabilities | 8,310.80 | 8,240.40 | 7,726.90 | 7,468.90 | 7,098.10 | |
ASSETS | ||||||
NON-CURRENT ASSETS | ||||||
Tangible Assets | 698.60 | 1,029.10 | 834.10 | 864.90 | 859.60 | |
Intangible Assets | 22.10 | 30.10 | 24.70 | 29.20 | 34.20 | |
Capital Work-In-Progress | 151.90 | 254.50 | 318.50 | 240.80 | 172.30 | |
Other Assets | 72.50 | 41.90 | 43.80 | 43.90 | 43.90 | |
Fixed Assets | 945.10 | 1,355.60 | 1,221.10 | 1,178.80 | 1,110.00 | |
Non-Current Investments | 4,814.00 | 3,902.80 | 3,745.20 | 3,363.50 | 3,210.60 | |
Deferred Tax Assets [Net] | 179.50 | 201.90 | 102.20 | 105.40 | 0.00 | |
Long Term Loans And Advances | 156.70 | 106.60 | 281.70 | 192.30 | 158.40 | |
Other Non-Current Assets | 131.80 | 227.10 | 319.00 | 250.40 | 248.00 | |
Total Non-Current Assets | 6,227.10 | 5,794.00 | 5,669.20 | 5,090.40 | 4,727.00 | |
CURRENT ASSETS | ||||||
Current Investments | 138.80 | 113.40 | 453.80 | 524.70 | 598.30 | |
Inventories | 534.70 | 801.90 | 561.70 | 539.60 | 504.60 | |
Trade Receivables | 573.20 | 901.80 | 739.90 | 798.20 | 503.80 | |
Cash And Cash Equivalents | 375.30 | 356.00 | 196.90 | 382.90 | 643.00 | |
Short Term Loans And Advances | 100.60 | 91.80 | 0.00 | 0.00 | 0.00 | |
OtherCurrentAssets | 361.10 | 181.50 | 105.40 | 133.10 | 121.40 | |
Total Current Assets | 2,083.70 | 2,446.40 | 2,057.70 | 2,378.50 | 2,371.10 | |
Total Assets | 8,310.80 | 8,240.40 | 7,726.90 | 7,468.90 | 7,098.10 | |
OTHER ADDITIONAL INFORMATION | ||||||
CONTINGENT LIABILITIES, COMMITMENTS | ||||||
Contingent Liabilities | 2,203.70 | 1,932.80 | 1,797.70 | 1,708.60 | 1,644.30 | |
CIF VALUE OF IMPORTS | ||||||
Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 556.10 | |
Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 57.80 | |
Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 57.80 | |
Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 97.50 | |
EXPENDITURE IN FOREIGN EXCHANGE | ||||||
Expenditure In Foreign Currency | 847.40 | 1,039.90 | 734.80 | 789.90 | 818.20 | |
REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
Dividend Remittance In Foreign Currency | -- | -- | -- | -- | 21.00 | |
EARNINGS IN FOREIGN EXCHANGE | ||||||
FOB Value Of Goods | -- | -- | -- | -- | -- | |
Other Earnings | 327.90 | 510.70 | 470.90 | 509.00 | 343.20 | |
BONUS DETAILS | ||||||
Bonus Equity Share Capital | 593.47 | 293.47 | 293.47 | 93.47 | 93.47 | |
NON-CURRENT INVESTMENTS | ||||||
Non-Current Investments Quoted Market Value | 6,798.30 | 8,374.10 | 8,672.40 | 7,562.20 | 5,580.00 | |
Non-Current Investments Unquoted Book Value | 2,149.80 | 1,236.80 | 1,022.00 | 640.30 | 487.20 | |
CURRENT INVESTMENTS | ||||||
Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
Current Investments Unquoted Book Value | 80.00 | 50.00 | 145.90 | 212.00 | 598.30 |
18.09.2025
18.09.2025
11.09.2025
05.09.2025
19.08.2025
Biocon Standalone June 2025 Net Sales at Rs 537.10 crore, up 5.19% Y-o-Y
08.05.2025
Biocon Consolidated March 2025 Net Sales at Rs 4,417.00 crore, up 12.76% Y-o-Y
08.05.2025
Biocon Standalone March 2025 Net Sales at Rs 643.80 crore, up 20.88% Y-o-Y
31.01.2025
Biocon Consolidated December 2024 Net Sales at Rs 3,821.40 crore, down 3.35% Y-o-Y